Comparing the rate of immunotherapy treatment change due to toxicity by sex

Comparing the rate of immunotherapy treatment change due to toxicity by sex

Abstract Background Immuno‐oncology therapy (IO) is associated with a variety of treatment‐related toxicities. However, the impact of toxicity on the treatment discontinuation rate between males and females is unknown. We hypothesized that immune‐related adverse events would lead to more frequent tr...

Full description

Bibliographic Details
Main Authors: Kevin J. Chua, Shane Kronstedt, Alain Kaldany, Arnav Srivastava, Sai Krishnaraya Doppalapudi, Hao Liu, Ahmad A. Tarhini, Margaret Gatti‐Mays, Elizabeth Gaughan, Siwen Hu‐Lieskovan, Raid Aljumaily, Kenneth Nepple, Bryan Schneider, Joshua Sterling, Eric A. Singer
Format: Article
Language:English
Published: Wiley 2024-02-01
Series:Cancer Reports
Subjects:
cancer
drug side effects
immunotherapy
oncology
sex differences
Online Access:https://doi.org/10.1002/cnr2.1932

Internet

https://doi.org/10.1002/cnr2.1932

Similar Items